Correction: EQL Pharma AB (publ) signs an asset purchase agreement in respect of the acquisition of a portfolio with original pharmaceuticals
Reading Time: 3 minutes NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OR TO ANY PERSON LOCATED OR RESIDENT IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL OR WOULD REQUIRE REGISTRATION OR OTHER MEASURES TO DISTRIBUTE THIS ANNOUNCEMENT. EQL
Aptahem’s Scientific Manuscript now Published in the British Journal of Pharmacology
Reading Time: 2 minutes Aptahem announced on 10 September 2024 that their scientific manuscript had been accepted for publication in the British Journal of Pharmacology (BJP). On the 9th December 2024, the article has been published. Read the article, titled “Antithrombotic but not anticoagulant activity
Theater Mogul’s “Defending the Caveman” Brings its Hilarious, Timeless Comedy to Mumbai
Reading Time: 3 minutes Mumbai has experienced and is applauding the laugh-out-loud humour of “Defending the Caveman,” the longest-running solo play in Broadway history, as it arrived in India for the first time! A comedic exploration of relationships, differences between men and women, and modern-day misunderstandings, this international sensation
JM acquiring building rights for residential development in Vaxholm
Reading Time: < 1 minute JM has signed an agreement with Brabo Stockholm AB for the acquisition of building rights for the development of approximately 60 residential units in Rindö Hamn, Vaxholm municipality. The transaction amounts to SEK 40m. The property being acquired is Rindö
Minesto completes Hestfjord Dragon Farm specification based on Dragon 12 achievements
Reading Time: 4 minutes After successful commissioning and four months of grid connected operation with Dragon 12, this autumn Minesto has focused on evaluation of powerplant performance, analysis of critical technical systems and operating procedures, as well as identification of selective upgrades of the megawatt-scale
BeiGene Advances Leadership in CLL at ASH 2024 with New Data From Its Hematology Franchise Including BRUKINSA® and Novel Pipeline Assets
Reading Time: 12 minutes San Mateo, Calif., United States: 5-year follow-up from SEQUOIA study demonstrated treatment with BRUKINSA reduced the risk of progression or death by 71% compared to bendamustine-rituximab in patients with treatment-naïve CLL, further solidifying its position as the leader in new
Buyers need market orientation and strategic capability to create customer value in public procurement
Reading Time: 2 minutes Public procurers should have a clear and well-communicated strategy, which is backed up by involvement of management and suitable resources, a recent study from the University of Eastern Finland shows. This kind of strategic procurement capability is associated with better customer value
Moloco Research Reveals Untapped Potential in Mobile Gaming App Marketing
Reading Time: 5 minutes New Delhi, Delhi, India: Mobile gaming app marketers may be missing out on opportunities to uncover high-value users and drive growth in global markets According to new research, 71% of mobile gaming app marketing spend is focused on
Kioxia Develops OCTRAM (Oxide-Semiconductor Channel Transistor DRAM) Technology
Reading Time: 3 minutes TOKYO, Japan: Kioxia Corporation, a world leader in memory solutions, today announced the development of OCTRAM (Oxide-Semiconductor Channel Transistor DRAM), a new type of 4F2 DRAM, comprised of an oxide-semiconductor transistor that has a high ON current, and an ultra-low OFF
Announcement of tender and exchange offers
Reading Time: 36 minutes THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE MARKET ABUSE REGULATION (EU) 596/2014. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO OR TO ANY